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How do you like Them Acots?
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Members of the acyl-CoA thioesterase (Acot) gene family
catalyze the hydrolysis of fatty acyl-CoA thioesters.
Thioesterase superfamily member (Them) 1 (synonym:
Acot11) is enriched in brown adipose tissue and is markedly
upregulated when mice are exposed to cold ambient
temperatures. In a recent study, we demonstrated that
Them1
−/− mice exhibit increased energy expenditure and are
resistant to diet-induced obesity and its metabolic conse-
quences. This mini-review places these findings in the context
of an emerging understanding of Them/Acot genes.
Introduction
Acyl-CoA thioesterases (Acots) are enzymes that catalyze the
hydrolysis of acyl-CoA molecules, including fatty acyl-CoAs.
1,2
Although their reactions are relatively well defined, the cellular
and biological consequences of Acot activity are poorly
understood. Hypotheses include control of the intracellular
balance between fatty acyl-CoAs and free fatty acids, the
intracellular and intra-organelle concentrations of coenzyme A
(CoASH) and the availability of fatty acids for the biosynthesis of
inflammatory mediators.
1,2
Acots have been identified in a broad array of organisms from
prokaryotes to mammals. In mammals, convergent evolution has
resulted in two structurally distinct types of Acot enzymes. Type I
enzymes (Acots 1–6) contain an a/β-hydrolase domain near the
C-terminus, which comprises all amino acid (aa) residues required
for catalysis, and typically an N-terminal regulatory acyl-CoA
thioester hydrolase domain that is not required for enzymatic
activity. Members of the a/β-hydrolase fold enzyme superfamily
include enzymes such as carboxyl-esterases and lipases. Type 1
Acots exhibit considerable aa sequence identity, ranging from 54–
98% for the human enzymes
3 and 65–94% for the mouse
enzymes.
1
Type II enzymes (Acots 7–13) share much lower degrees of
sequence identity (typically , 25%)
1,3 and are instead related by a
common hotdog fold structural motif.
1 The “hotdog” domain
proteins contain highly divergent sequences that fold to create
very well conserved structural elements in which an antiparallel
β-sheet is the “bun,” which wraps around an a-helical “hotdog.”
4
With the exception of Acot13, which consists of a single hotdog
fold domain, the other established type II Acots (i.e., Acots 7–12)
comprise tandem hotdog fold domains. The significance of
tandem hotdog fold thioesterase domains is presumably related to
the requirement that these structures oligomerize to create enzyme
active sites. Uniquely, Acots 11 and 12 each contain a C-terminal
lipid-binding steroidogenic acute regulatory transfer-related
(START) domain.
Because type II enzymes are related principally by structure and
not sequence, the possibility remains open that more family
members exist than are currently designated as Acots. Important
examples are four genes that were each categorized as a
thioesterase superfamily member (Them). The corresponding
proteins were not initially appreciated because of their enzymatic
activities, but were subsequently understood to function as Acots.
Recent studies of these Them genes have provided considerable
new insights into the biological functions of Acots in nutrient
metabolism and energy homeostasis.
Them1 (Acot11)
Them1 was initially named brown fat inducible thioesterase (BFIT)
because it is highly enriched in brown adipose tissue (BAT), with
much lower expression levels in other tissues, including white
adipose, brain, liver, skeletal muscle, kidney, heart and testis, and
because it was markedly upregulated when mice were exposed to
cold ambient temperatures.
5 When taken together with the
observation that Them1 gene expression was higher in BAT of
mouse strains that were resistant to diet-induced obesity, it was
predicted that Them1 might function to promote energy
expenditure. Although not systematically characterized as an
enzyme, the same investigators commented that recombinant
Them1 functioned as a medium- to long-chain fatty acyl-CoA
thioesterase. Them1 was subsequently incorporated into the Acot
familyasAcot11
6andintotheSTARTdomainfamilyasStarD14.
7,8
Our own attention was drawn to Them1 because of its ties to
both the Acot and START domain gene families. In an effort to
understand the regulatory effects of another START domain
protein, phosphatidylcholine transfer protein (PC-TP; synonym,
StarD2) in hepatic glucose and lipid metabolism
9 and energy
homeostasis,
9,10 we performed a yeast two-hybrid screen that
identified Them2 as a PC-TP-binding protein.
11 The motivation
for seeking a binding partner was that PC-TP is an example of a
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pocket, but contains no other apparent functional domains.
8 It
was curious to unearth an interaction between a START minimal
domain protein and a hotdog fold thioesterase, when two related
proteins (i.e., Them1 and Acot12) each contained tandem hotdog
fold thioesterase domains plus a START domain within the same
multidomain protein.
To test its own role in nutrient metabolism and energy
homeostasis, we created Them1
−/− mice.
12 Unexpectedly, Them1
−/−
mice exhibited increased energy expenditure and were resistant to
diet-induced obesity, as well as associated metabolic disorders.
Increased concentrations of fatty acyl-CoAs in BAT and decreased
thioesterase activities of BAT homogenates suggested that Them1
functions as an Acot in vivo. Consistent with increased rates of
energy expenditure, rates of fatty acid oxidation in BAT were
increased in the absence of Them1 expression.
Them1
−/− mice also displayed resistance to diet induced
inflammation in white adipose tissue (WAT) and to hepatic
steatosis and insulin resistance. Whereas these effects may have
been ascribed to increased energy consumption by BAT, the data
indicated that Them1 expression in WAT and liver per se played
important roles in the development of obesity-associated
metabolic disorders. In WAT, Them1 expression was upregulated
several-fold in response to high fat feeding. Using white
adipocytes from chow-fed animals, we demonstrated a reduced
capacity of conditioned media to activate cultured wild type
macrophages. This suggested the possibility that Them1 activity
in wild type adipocytes led to the release of one or more pro-
inflammatory molecules, possibly including free fatty acids. Along
similar lines, endoplasmic reticulum (ER) stress led to upregula-
tion of Them1 expression in mouse liver, and livers of Them1
−/−
mice exhibited reduced response to ER stress. This effect appeared
to be cell autonomous, as evidence by reduced ER stress responses
in cultured hepatocytes and MEFs prepared from Them1
−/− mice.
Collectively, these observations suggest a pathogenic role for
Them1 in the metabolic abnormalities that accompany over-
nutrition, potentially by liberating excess free fatty acids
intracellularly.
Although the molecular mechanism by which Them1 reduces
energy consumption is not yet known, a key regulatory role for
this enzyme is in line with evidence that interconversion of free
fatty acids and fatty acyl-CoAs is important for the control of
thermogenesis in BAT. Studies in mice with adipose-specific
deletion of long-chain acyl-CoA synthetase 1 (ASCL1), which
catalyzes the formation of fatty acyl-CoA thioesterases from free
fatty acids and CoASH, have revealed that activation of free fatty
acids to form fatty acyl-CoAs facilitates their mitochondrial
oxidation in BAT.
13 By reversing this reaction, Them1 could play
an important role in reducing rates of fatty acid oxidation. We
also provided evidence in Them1
−/− mice for the differential
regulation of genes that are under the control of fatty acid-
activated nuclear hormone receptors that transcriptionally regulate
BAT differentiation and thermogenesis (e.g., PPARc and
PPARa). This suggests that Them1 activity may regulate
intracellular concentrations of selected ligands, which activate
these nuclear hormone receptors.
2,13
Whereas our paper suggests that Them1 functions in vivo as an
acyl-CoA thioesterase, additional mechanistic insights into
metabolic regulation and energy homeostasis will no doubt
emerge from a deeper understanding of both the cellular biology
and the structure-function relationships of the protein. Using
subcellular fractionation techniques, we found that Them1 was
mainly concentrated in the ER and to a lesser extent mitochondria
and cytosol. In liver, the protein was mainly concentrated in
cytosol. However, unlike the other Them proteins discussed
below, Them1 was not identified as a component of the
mitochondrial proteome.
14 A clearer understanding of the cellular
localization and its determinants would contribute to our
understanding of Them1’s biological function.
At present, neither the enzymatic characteristics of Them1 nor
the lipid ligand of the START domain have been elucidated.
Whereas the crystal structure of the unliganded Them1 START
domain revealed a hydrophobic binding pocket, it did not provide
firm clues as to the identity of the endogenous ligand.
15 A number
of lines of indirect evidence led the authors to propose that fatty
acids ranging up to 18 carbons could constitute the natural
ligands. Once a ligand is identified, it will be important to discern
whether its binding to the START domain regulates the
enzymatic activity of Them1. Knowledge of the enzymatic
characteristics and endogenous ligand should also help to
determine the feasibility of targeting Them1 for the management
of obesity and its associated metabolic disorders.
Them2 (Acot13)
Them2 was first identified as a component of the mouse
mitochondrial proteome.
16 It is broadly expressed,
17 with highest
levels in liver and oxidative tissues including heart, kidney and
BAT.
18 The crystal structure of human Them2 revealed a
homotetrameric assembly of back-to-back hotdog folds.
19
Whereas an initial substrate survey suggested that Them2
primarily hydrolyzes a polar aromatic CoA thioester,
19 subsequent
analyses by our group
18 and another
20 concluded that the
endogenous substrates of Them2 were likely to be medium-
and long-chain fatty acyl-CoAs. This led to the inclusion of
Them2 within the Acot family as Acot13.
18
To understand the biological functions of Them2, we created
Them2
−/− mice.
21 In livers of Them2
−/− mice compared with
Them2
+/+ controls, a decrease in mitochondrial thioesterase
activity was accompanied by an increase in hepatic concentrations
of long-chain fatty acyl-CoAs and a reciprocal decrease in free
fatty acid concentrations. Fatty acid oxidation rates were
unchanged in livers of Them2
−/− mice despite reduced activation
of PPARa. This suggested that Them2 functions, at least in part,
to limit β-oxidation. In the setting of reduced HNF4a expression,
rates of hepatic glucose production were also decreased in chow
fed mice. Considering that fatty acids are putative ligands for both
PPARa and HNF4a,
22,23 these findings further suggested that
Them2 regulates activation of these nuclear receptors in the liver,
a possibility that was supported by promoter-reporter experiments
in a cell culture system. When fed a high fat diet, Them2
−/− mice
were also resistant to increases in hepatic glucose production and
4 Adipocyte Volume 2 Issue 1steatosis. Taken together, these findings revealed a key role for
Them2 in regulating lipid and glucose metabolism in the liver.
Having identified Them2 as PC-TP binding protein,
11 we
sought evidence of a functional interaction between these two
proteins. Accordingly, the in vitro fatty acyl-CoA thioesterase
activity of purified recombinant Them2 was increased by the
addition of purified recombinant PC-TP.
11,18 Circumstantial
evidence of a biologically impactful interaction included the
observations that both proteins are enriched in liver and oxidative
tissues and are transcriptionally upregulated by PPARa.
18,24 Cell
fractionation studies and confocal microscopy revealed that
Them2 is primarily associated with mitochondria, but is also
present in cytosol.
11,18 This is complementary to the subcellular
distribution of PC-TP, which is enriched in cytosol, but has an
appreciable fraction that associates with mitochondria.
11,18,25
Moreover, experiments in cell culture systems
25 have revealed
that PC-TP may relocate from cytosol to mitochondria in
response to certain PKA agonists, with indirect evidence to
suggest that phosphorylation is the mechanism. As observed with
Them2 in promoter-reporter experiments, PC-TP expression
similarly regulated the transcriptional activity of both PPARa and
HNF4a.
24 Finally, Pctp
−/− mice exhibit increased hepatic insulin
sensitivity
9 and are also resistant to high fat diet-induced increases
in hepatic glucose production.
26 Although Pctp
−/− mice do not
entirely phenocopy Them2
−/− mice, key similarities suggest that
Them2-PC-TP interactions regulate fatty acid oxidation and
glucose production by the liver.
Them4
Them4 was initially identified as the C-terminal modulator
protein (CTMP). Mainly expressed in skeletal muscle, testis,
uterus, brain and kidney, Them4 specifically binds to the
carboxyl-terminal regulatory domain of Akt/PKBa at the plasma
membrane.
27 In this study, binding of Them4 at the plasma
membrane was shown to reduce Akt activity, as evidenced by
decreases in phosphorylation at S473 and T308. This in turn
decreased insulin and insulin-like growth factor 1 (IGF-1)
signaling. Interestingly, Them4 is a nuclear-encoded mitochon-
dria-associated protein,
14 which is targeted to the inner
mitochondrial membrane and the inner mitochondrial space.
28
There it regulates mitochondrial dynamics, appearing to play a
role in the fission process.
29 Them4 is released from mitochon-
dria in response to stimuli that promote apoptosis and helps to
facilitate apoptosis by inhibiting Akt activation.
28 In a separate
study of relatively similar design, Them4 was shown to induce
Akt phosphorylation and reduce apoptosis,
30 although the reason
for this discrepancy is unclear.
31 In hippocampal neurons,
Them4 was found within cytosol, where it suppressed Akt
activity and promoted ischemia-induced neuronal cell death.
32
Based upon a bioinformatics analysis suggesting that Them4
belonged to the hotdog fold thioesterase family, the protein was
modeled as a tetramer similar to Them2 and shown to hydrolyze
a broad range of substrates including medium- to long-chain
fatty acyl-CoAs.
33 Consequently, it has been proposed that
Them4 be incorporated into the Acot family as Acot14.
3 At
present, it is unclear whether a relationship exists between the
enzymatic activity of Them4 and its regulatory activity in cell
signaling.
Them5 (Acot15)
Them5 is a mitochondrial protein
14 that is localized to the matrix
by a targeting sequence that is subsequently cleaved.
34 Like
Them2 and Them4, it is a single domain hotdog fold thioesterase.
In accordance with its crystal structure, a recent study showed that
Them5 forms a homodimer in solution with enzymatic selectivity
for medium- to long-chain fatty acyl-CoAs, particularly linoleoyl-
CoA.
34 As a result, Them5 has been newly incorporated into the
Acot family as Acot15. Although the tissue distribution of Them5
has not been reported, the same paper demonstrated that liver
mitochondria from Them5
−/− mice are characterized by a
reduction in cardiolipin, an important constituent of the inner
mitochondrial membrane. There was a reciprocal increase in the
precursor monolyso-cardiolipin, suggesting that Them5 plays a
key role in regulating the remodeling of mitochondria that is
critical for optimal functioning of the electron transport chain.
Them5
−/− mice exhibited mitochondrial dysfunction as evidenced
by measurements in cells and isolated mitochondria. There were
also changes in morphology, with increased sizes as well as the
development of interconnections among mitochondria. Loss of
Them5 expression led to a decrease in mitochondrial free fatty
acid concentrations, particularly C18 polyunsaturated fatty acids.
These decreases were apparently due to the export of fatty acids
into the cytosol, where they accumulated and may have
contributed to the age-dependent development of fatty liver in
Them5
−/− mice. This was accompanied by decreased fatty acid
oxidation, which likely also played a role in the development of
fatty liver and was attributable, at least in part, to the failure of re-
feeding to induce fatty acid synthase expression in livers of
Them5
−/− mice.
Conclusions
Although they have come to attention for different reasons,
collectively the Them genes now appear to play key regulatory
roles in fatty acid and glucose metabolism and in mitochondrial
function. These initial studies, which have begun to shed light on
the biological roles of Acots, further suggest that efforts to
delineate the functions of other type I and type II Acot genes
should broaden our understanding of metabolic regulation, as well
as the consequences of overnutrition and obesity.
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